Norland Medical Systems (the Netherlands) reduces Ostech holding with 2 million share offering
This article was originally published in Clinica
Norland Medical Systems (the Netherlands) is reducing to 50% its ownership of Ostech, a US distributor of bone densitometry systems, through an offering of 2 million shares at $10.50 each. Ostech, which achieved a net income of $68,044 on revenues of $10.04 million in 1994, began operations in January 1994 as the exclusive distributor of systems produced by Norland (US) and Stratec Medizintechnik (Germany), both owned by NMS.
You may also be interested in...
The director of adult immunizations at Johns Hopkins International Vaccine Access Center talks to Scrip about undertaking a massive COVID-19 vaccination effort in the US.
P&G’s oral care business drove 35% of total category market growth in the firm’s fiscal 2020 and exemplifies its growth strategy for all segments – grow entire categories rather than take competitors’ market share, says CFO Jon Moeller.
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.